Pediatric Cardiology

, Volume 38, Issue 5, pp 959–964 | Cite as

Hyperoxia Reduces Oxygen Consumption in Children with Pulmonary Hypertension

  • Long Guo
  • Prashant Bobhate
  • Shine Kumar
  • Karunakar Vadlamudi
  • Tarek Kaddoura
  • Mohamed Elgendi
  • Paula Holinski
  • James Y. Coe
  • Jennifer Rutledge
  • Ian Adatia
Original Article

Abstract

High inspired oxygen concentration (FiO2 > 0.85) is administered to test pulmonary vascular reactivity in children with pulmonary hypertension (PH). It is difficult to measure oxygen consumption (VO2) if the subject is breathing a hyperoxic gas mixture so the assumption is made that baseline VO2 does not change. We hypothesized that hyperoxia changes VO2. We sought to compare the VO2 measured by a thermodilution catheter in room air and hyperoxia. A retrospective review of the hemodynamic data obtained in children with PH who underwent cardiac catheterization was conducted between 2009 and 2014. Cardiac index (CI) was measured by a thermodilution catheter in room air and hyperoxia. VO2 was calculated using the equation CI = VO2/arterial–venous oxygen content difference. Data were available in 24 subjects (males = 10), with median age 8.3 years (0.8–17.6 years), weight 23.3 kg (7.5–95 kg), and body surface area 0.9 m2 (0.4–2.0 m2). In hyperoxia compared with room air, we measured decreased VO2 (154 ± 38 to 136 ± 34 ml/min/m2, p = 0.007), heart rate (91 \(\pm\) 20 to 83 \(\pm\) 21 beats/minute, p=0.005), mean pulmonary artery pressure (41 \(\pm\) 16 to 35 \(\pm\) 14 mmHg, p=0.024), CI (3.6 \(\pm\) 0.8 to 3.3 \(\pm\) 0.9 L/min/m2, p = 0.03), pulmonary vascular resistance (9 \(\pm\) 6 to 7 \(\pm\) 3 WU m2, p = 0.029), increased mean aortic (61 \(\pm\) 11 to 67 \(\pm\) 11 mmHg, p = 0.005), pulmonary artery wedge pressures (11 \(\pm\) 8 to 13 \(\pm\) 9 mmHg, p = 0.006), and systemic vascular resistance (12 \(\pm\) 6 to 20 \(\pm\) 7 WU m2, p=0.001). Hyperoxia decreased VO2 and CI and caused pulmonary vasodilation and systemic vasoconstriction in children with PH. The assumption that VO2 remains unchanged in hyperoxia may be incorrect and, if the Fick equation is used, may lead to an overestimation of pulmonary blood flow and underestimation of PVRI.

Keywords

Pulmonary hypertension Oxygen consumption Cardiac catheterization Pulmonary vasoreactivity Hyperoxia Thermodilution 

Notes

Funding

Dr. Adatia’s research was funded by a Women and Children’s Health Research Institute and Stollery Children’s Hospital Foundation Grant. A Deloitte Clinical Research Fellowship and Stollery Children’s Hospital Foundation Academic Fellowship supported Dr. Long Guo’s salary.

Compliance with Ethical Standards

Conflict of interest

All of the authors (Long Guo, Prashant Bobhate, Shine Kumar, Karunakar Vadlamudi, Tarek Kaddoura, Mohamed Elgendi, Paula Holinski, James Y Coe, Jennifer Rutledge, Ian Adatia) declare that they have no conflicts of interest related to the material or subject of this manuscript.

Ethical Approval

The study was performed in accordance with the ethical standards of and with the approval of the University of Alberta Research Ethics Committee for research involving human subjects, who waived the need for individual consent because it was a retrospective study.

References

  1. 1.
    Hill KD, Lim DS, Everett AD, Ivy DD, Moore JD (2010) Assessment of pulmonary hypertension in the pediatric catheterization laboratory: current insights from the magic registry. Catheter Cardiovasc Interv 76:865–873CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Barst RJ, Agnoletti G, Fraisse A, Baldassarre J, Wessel DL (2010) Vasodilator testing with nitric oxide and/or oxygen in pediatric pulmonary hypertension. Pediatr Cardiol 31:598–606CrossRefPubMedGoogle Scholar
  3. 3.
    Atz AM, Adatia I, Lock JE, Wessel DL (1999) Combined effects of nitric oxide and oxygen during acute pulmonary vasodilator testing. J Am Coll Cardiol 33:813–819CrossRefPubMedGoogle Scholar
  4. 4.
    Bush A, Busst CM, Shinebourne EA (1985) The use of oxygen and prostacyclin as pulmonary vasodilators in congenital heart disease. Int J Cardiol 9:267–274CrossRefPubMedGoogle Scholar
  5. 5.
    Bush A, Busst C, Booth K, Knight WB, Shinebourne EA (1986) Does prostacyclin enhance the selective pulmonary vasodilator effect of oxygen in children with congenital heart disease?. Circulation 74:135–144CrossRefPubMedGoogle Scholar
  6. 6.
    Beekman RH, Rocchini AP, Rosenthal A (1983) Cardiovascular effects of breathing 95% oxygen in children with congenital heart disease. Am J Cardiol 52:106–111CrossRefPubMedGoogle Scholar
  7. 7.
    Marshall HW, Swan HJC, Burchell HB, Wood EH (1961) Effect of breathing oxygen on pulmonary artery pressure and pulmonary vascular resistance in patients with ventricular septal defect. Circulation 23:241–252CrossRefPubMedGoogle Scholar
  8. 8.
    Moradkhan R, Sinoway LI (2010) Revisiting the role of oxygen therapy in cardiac patients. J Am Coll Cardiol 56:1013–1016CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Waring WS, Thomson AJ, Adwani SH, Rosseel AJ, Potter JF, Webb DJ, Maxwell SR (2003) Cardiovascular effects of acute oxygen administration in healthy adults. J Cardiovasc Pharmacol 42:245–250CrossRefPubMedGoogle Scholar
  10. 10.
    Bobhate P, Guo L, Jain S, Haugen R, Coe JY, Cave D, Rutledge J, Adatia I (2015) Cardiac catheterization in children with pulmonary hypertensive vascular disease. Pediatr Cardiol 36:873–879CrossRefPubMedGoogle Scholar
  11. 11.
    Guo L, Cui Y, Pharis S, Walsh M, Atallah J, Tan MW, Rutledge J, Coe JY, Adatia I (2014) Measurement of oxygen consumption in children undergoing cardiac catheterization: comparison between mass spectrometry and the breath-by-breath method. Pediatr Cardiol 35:798–802CrossRefPubMedGoogle Scholar
  12. 12.
    Lock JE, Einzig S, Bass JL, Moller JH (1982) The pulmonary vascular response to oxygen and its influence on operative results in children with ventricular septal defect. Pediatr Cardiol 3:41–46CrossRefPubMedGoogle Scholar
  13. 13.
    Gan HL, Zhang JQ, Zhou QW, Feng L, Chen F, Yang Y (2014) Patients with congenital systemic-to-pulmonary shunts and increased pulmonary vascular resistance: what predicts postoperative survival? PloS ONE 9:e83976CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Balzer DT, Kort HW, Day RW, Corneli HM, Kovalchin JP, Cannon BC, Kaine SF, Ivy DD, Webber SA, Rothman A, Ross RD, Aggarwal S, Takahashi M, Waldman JD (2002) Inhaled nitric oxide as a preoperative test (INOP test I): the INOP test study group. Circulation 106:I76–81PubMedGoogle Scholar
  15. 15.
    Neutze JM, Ishikawa T, Clarkson PM, Calder AL, Barratt-Boyes BG, Kerr AR (1989) Assessment and follow-up of patients with ventricular septal defect and elevated pulmonary vascular resistance. Am J Cardiol 63:327–331CrossRefPubMedGoogle Scholar
  16. 16.
    Daly WJ, Bondurant S (1962) Effects of oxygen breathing on the heart rate, blood pressure, and cardiac index of normal men-resting, with reactive hyperemia, and after atropine. J Clin Invest 41:126–132CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Anderson KJ, Harten JM, Booth MG, Berry CB, McConnachie A, Rankin AC, Kinsella J (2010) The cardiovascular effects of normobaric hyperoxia in patients with heart rate fixed by permanent pacemaker. Anaesthesia 65:167–171CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2017

Authors and Affiliations

  • Long Guo
    • 1
    • 2
  • Prashant Bobhate
    • 1
    • 2
    • 7
  • Shine Kumar
    • 1
    • 2
    • 8
  • Karunakar Vadlamudi
    • 1
    • 2
  • Tarek Kaddoura
    • 5
  • Mohamed Elgendi
    • 6
    • 9
  • Paula Holinski
    • 1
    • 2
    • 3
  • James Y. Coe
    • 4
  • Jennifer Rutledge
    • 4
  • Ian Adatia
    • 1
    • 2
    • 10
  1. 1.Pediatric Cardiac Intensive Care, Mazankowski Alberta Heart InstituteStollery Children’s HospitalEdmontonCanada
  2. 2.Pulmonary Hypertension Service, Mazankowski Alberta Heart InstituteStollery Children’s HospitalEdmontonCanada
  3. 3.Pediatric Anesthesia, Mazankowski Alberta Heart InstituteStollery Children’s HospitalEdmontonCanada
  4. 4.Pediatric Cardiology, Mazankowski Alberta Heart InstituteStollery Children’s HospitalEdmontonCanada
  5. 5.Department of Electrical and Computer EngineeringUniversity of AlbertaEdmontonCanada
  6. 6.Department of Computing ScienceUniversity of AlbertaEdmontonCanada
  7. 7.Children’s Heart CenterKokilaben Dhirubhai Ambani HospitalMumbaiIndia
  8. 8.Pediatric Cardiology, Amrita School of MedicineAmrita Vishwa Vidyapeetham UniversityKochiIndia
  9. 9.Electrical and Computer Engineering in Medicine GroupUniversity of British Columbia and BC Children’s HospitalVancouverCanada
  10. 10.Stollery Children’s HospitalEdmontonCanada

Personalised recommendations